Wardman M, Chintakayala PK, de Jong G. Values of travel time in Europe: review and meta-analysis. Transp Res Part A Policy Pract. 2016 Dec;94:93-111. doi: 10.1016/j.tra.2016.08.019
Graham J, Earnshaw S, Lim J, Luthra R, Borker R. Cost-effectiveness of afatinib versus erlotinib in the first-line treatment of patients with metastatic non-small cell lung cancer with EGFR Exon 19 deletion mutations. JCP. 2016 May;2(4):31-9.
Frye S, Crosby M, Edwards TP, Juliano R. US academic drug discovery. Nat Rev Drug Discov. 2011 Jun 1;10(6):409-10. doi: 10.1038/nrd3462